设正点财经为首页     加入收藏
首 页 财经新闻 主力数据 财经视频 研究报告 证券软件 内参传闻 股市学院 指标公式
你的位置: > 正点财经 > 研究报告 > 正文

China Healthcare:Stable growth in April

类型:行业研究  机构:德意志银行   研究员:Jack Hu  日期:2017-05-18
http://www.zdcj.net      点击收藏此报告
    

11.2% YoY growth in YTD4m17, vs. FY16growth of 12.0%

    Growth of retail drug consumption continued to strengthen, recording 12.6%YoY in April, compared with 10.7% in 1Q17. On a quarterly basis, growth in1Q17was 10.7%, compared with 10.7%, 11.1%, 11.6%, 15.1%, and 14.4% in4Q16, 3Q16, 2Q16, 1Q16and 4Q15respectively. We remind investors thatdrug consumption data have high correlation with hospital drug sales.

    We remain constructive on the sector

    We remain constructive on the healthcare sector in 2017on the back ofimproved regulatory environment, increased reimbursement coverage anddecreasing pricing pressure from drug tenders. We advise investors to focuson companies with new product launches and existing products with limitedpricing pressure such as CBPO (CBPO.OQ) and Hengrui (600276.SS).

相关报告:
热点推荐:
更多最新研究报告
更多财经新闻
  • 如果不能阅读报告,请点击下载阅读器
关于我们 | 商务合作 | 联系投稿 | 联系删稿 | 合作伙伴 | 法律声明 | 网站地图